Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning by co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deliberate overdose of paracetamol (disorder) |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Deliberate overdose of co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen blood measurement (procedure) |
Component |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Serum paracetamol measurement (procedure) |
Component |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental acetaminophen poisoning |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional paracetamol poisoning |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen poisoning of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen and dextropropoxyphene poisoning of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental poisoning by co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning by co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction to acetaminophen |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol allergy |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen overdose |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental paracetamol overdose (disorder) |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen overdose of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol and dextropropoxyphene overdose of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Overdose of co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental overdose by co-proxamol |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Overdose of co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 500mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 24 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 100 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 240 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 60 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 120mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 125 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 120mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 120mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 250mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 500mg/5mL s/f suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 120mg paediatric soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 80mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 325 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 80 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 160 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 80mg/0.8mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 80mg/2.5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 80mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 160mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 500mg/15mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + chloralantipyrine + isometheptene mucate (1:1) 325mg/100mg/65mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen+chlorpheniramine maleate+phenylephrine hydrochloride 500mg/8mg/40mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + alcohol + codeine phosphate 120mg/7%vv/12mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + codeine phosphate 120mg/12mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen+codeine phosphate 300mg/30mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + oxycodone hydrochloride 325mg/5mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + oxycodone hydrochloride 500mg/5mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxycodone hydrochloride 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + pentazocine hydrochloride 650mg/ns caplet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 125mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 120mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 160mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen 250mg oro-dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol 1g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen measurement |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen measurement, urine (procedure) |
Component |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Poisoning by paracetamol |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol+methionine 500mg/250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-codamol 8mg/500mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-proxamol 32.5mg/325mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol+codeine phosphate 500mg/30mg/sachet powder (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-proxamol 32.5mg/325mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|